Effect of polymeric nanoparticle administration on the clearance activity of the mononuclear phagocyte system in mice

Journal of Biomedical Materials Research

Volumn 31, Issue 3, 1996, Pages 401-408

  Fernandez Urrusuno R ^a   Fattal, E ^a   Rodrigues Jr , J M ^a   Feger J ^a   Bedossa, P ^b   Couvreur, P ^a  

^a UNIVERSITÉ PARIS SACLAY   (France)

^b Service d'Anatomie Pathologique   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMATERIALS; MEDICAL PROBLEMS; POLYACRYLATES; POLYSTYRENES;

BLOOD PLASMA; PHAGOCYTE SYSTEM;

BLOOD;

DRUG CARRIER; FIBRONECTIN; NANOPARTICLE; OPSONIN; POLY(ISOBUTYL 2 CYANOACRYLATE); POLY(ISOHEXYL 2 CYANOACRYLATE); POLYLACTIC ACID; POLYSTYRENE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG ACCUMULATION; DRUG DELIVERY SYSTEM; FEMALE; KUPFFER CELL; LIVER TOXICITY; MOUSE; NONHUMAN; PHAGOCYTE; SPLEEN CELL;

ANIMALS; FEMALE; FIBRONECTINS; INJECTIONS, INTRAVENOUS; LIVER; MICE; MICE, INBRED STRAINS; MICROSPHERES; MONOCYTES; OPSONIN PROTEINS; ORGAN SIZE; PHAGOCYTOSIS; POLYMERS;

EID: 0030199872     PISSN: 00219304     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4636(199607)31:3<401::AID-JBM15>3.0.CO;2-L     Document Type: Article

References (44)

1. V. Lenaerts, J. F. Nagerlkerke, T. J. C. Van Berkerl, P. Couvreur, L. Grislain, M. Roland, and P. Speiser, "In vivo uptake of polyisobutylcyanoacrylate nanoparticles by the rat liver Kupffer, endothelial and parenchymal cells," J. Pharm. Sci., 73, 980-982 (1984).
2. M. Youssef, E. Fattal, M. J. Alonso, L. Roblot-Treupel, J. Sauzieres, C. Tancrede, A. Omnes, P. Couvreur, and A. Andremont, "Effectiveness of nanoparticles bound ampicillin in treatment of Listeria monocytogenes infections in nude mice," Antimicrob. Agents Chemother., 32, 1204-1207 (1988).
3. E. Fattal, M. Youssef, P. Couvreur, and A. Andremont, "Treatment of experimental salmonellosis in mice with ampicillin-bound nanoparticles," Antimicrob. Agents Chemother., 33, 1540-1543 (1989).
4. N. Chiannilkulchai, Z. Driouich, J. P. Benoit, A. L. Parodi, and P. Couvreur, "Doxorubicin-loaded nanoparticles: Increased efficiency in murine hepatic metastases," Select. Cancer Ther., 5, 1-11 (1989).
5. K. R. Patel, M. P. Li, and J. P. Baldeschwieler, "Suppression of liver uptake of liposomes by dextran sulfate 500," Proc. Natl. Acad. Sci., 80, 6518-6522 (1983).
6. G. Hennighausen and M. Engel, "Depletion of hepatic glutathione in rats impairs phagocytosis in vivo," Arch. Toxicol. Suppl. 13, 326-329 (1989).
7. M. J. Hardonk, F. W. J. Dijkhuis, C. E. Hulstaert, and J. Koudstaal, "Heterogeneity of rat liver and spleen macrophages in gadolinium chloride-induced elimination and repopulation," J. Leukoc. Biol., 52, 296-302 (1992).
8. H. Ellens, E. Mayhew, and Y. M. Rustum, "Reversible depression of the reticuloendothelial system by liposomes," Biochim. Biophys. Acta, 714, 479-485 (1982).
9. E. A. H. Weereratne, G. Gregoriadis, and J. Crow, "Toxicity of sphingomyelin-containing liposomes after chronic injection into mice," Br. J. Exp. Pathol., 64, 670-676 (1983).
10. T. M. Allen, L. Murray, S. MacKeigan, and M. Shah, "Chronic liposome administration in mice: Effects on reticuloendothelial function and tissue distribution," J. Pharmacol. Exp. Ther., 229, 267-275 (1984).
11. M. Kanke, R. G. Geissler, D. Powell, A. Kaplan, and P. P. DeLuca, "Interaction of microspheres with blood constituents III. Macrophage phagocytosis of various types of polymeric drug carriers," J. Parent. Sci. Technol., 42, 157-165 (1988).
12. P. Artursson, E. Arro, P. Edman, J. L. E. Ericsson, and I. Sjoholm, "Biodegradable microspheres V: Stimulation of macrophages with microparticles made of various polysaccharides," J. Pharm. Sci., 76, 127-133 (1987).
13. B. Kante, P. Couvreur, G. Dubois-Krack, C. De Meester, P. Guiot, M. Roland, and P. Speiser, "Toxicity of polyalkylcyanoacrylate nanoparticles I: Free nanoparticles," J. Pharm. Sci., 71, 786-790 (1982).
14. R. Gaspar, V. Preat, R. R. Opperdoes, and M. Roland, "Macrophage activation by polymeric nanoparticles of polyalkylcyanoacrylates: Activity against intracellular Leishmania donovani associated with hydrogen peroxide production," Pharm. Res., 9, 782-787 (1992).
15. C. A. Toth and P. Thomas, "Liver endocytosis and Kupffer cells," Hepatology, 16, 255-266 (1992).
16. S. M. Moghimi and S. S. Davis, "Innovation in avoiding particle clearance from blood by Kupffer cells: Cause for reflection," Crit. Rev. Ther. Drug Carrier Syst., 11, 31-59 (1994).
17. J. A. M. Langermans, W. L. W. Hazenbos, and R. Van Furth, "Antimicrobial functions of mononuclear phagocytes," J. Immunol. Methods., 174, 185-194 (1994).
18. T. M. Allen, "Toxicity of drug carriers to the mononuclear phagocyte system," Adv. Drug Deliv. Rev., 2, 55-67 (1988).
19. M. D. Witmer-Pack, M. T. Crowley, K. Inaba, and R. M. Steinman, "Macrophages, but not dendritic cells, accumulate colloidal carbon following administration in situ," J. Cell Sci., 105, 965-973 (1993).
20. P.M. Cardarelli, F. A. Blumenstock, P. J. McKeown-Longo, T. M. Saba, J. E. Mazurkiewicz, and J. A. Dias, "High-affinity binding of fibronectin to cultured Kupffer cells," 45, 426-437 (1990).
21. H. Schreier, R. M. Abra, J. E. Kaplan, and C. A. Hunt, "Murine plasma fibronectin depletion after intravenous injection of liposomes," Int. J. Pharmacol. 37, 233-238 (1987).
22. F. A. Blumenstock, P. La Celle, A. Herrmannsdoerfer, C. Giunta, F. L. Minnear, E. Cho, and T. M. Saba, "Hepatic removal of 125I-DLT gelatin after burn injury: A model of soluble collagenous debris that interacts with plasma fibronectin,". J. Leukoc. Biol., 54, 56-64 (1993).
23. J. H. Elam, C. H. Karlsson, and H. Hygren, "Preadsorption of a cellulose ether onto polymer surfaces: Adsorption of adhesins and platelet activation," Biomaterials, 14, 233-237 (1993).
24. P. Couvreur, B. Kante, M. Roland, P. Guiot, P. Bauduin, and P. Speiser, "Polyalkylcyanoacrylate nanocapsules as potential lysosomotropic carrier: preparation, morphological and sorptive properties," J. Pharm. Pharmacol., 31, 331-332 (1979).
25. H. Fessi, J. P. Devissaguet, and P. Puisieux, "Procédé de preparation de systèmes colloidaux dispersibles d'une substance sous forme de nanocapsules," European Patent Application 0274961. A1, July 20, 1988.
26. T. M. Sabe, "Physiology and physiopathology of the reticuloendothelial system," Arch. Intern. Med., 126, 1031-1052 (1970).
27. L. Bouwens, P. Bleser, K. Vanderkerken, B. Geerts, and E. Wisse, "Liver cell heterogeneity: Functions of non-parenchymal cells," Enzyme, 46, 155-168 (1992).
28. F. Blumenstock, P. Weber, T. M. Saba, and R. Laffin, "Electroimmunoassay of alpha-2-opsonic protein during reticuloendothelial blockade," Am. J. Physiol., 232, R80-R87 (1977).
29. Y. J. Kao and R. L. Juliano, "Interactions of liposomes with the reticuloendothelial system I. Effects of reticuloendothelial blockade on the clearance of large unilamellar vesicles." Biochim. Biophys. Acta, 677, 453-461 (1981).
30. V. Kolb-Bachofen, "Uptake of toxic silica particles by isolated liver macrophages (Kupffer cells) in receptor mediated and can be blocked by competition," J. Clin. Invest., 90, 1819-1824 (1992).
31. R. L. Souhami and J. W. B. Bradfield, "The recovery of hepatic phagocytosis after blockade of Kupffer cells," J. Reticuloendothelial Soc., 16, 75-86 (1974).
32. T. Blunk, D. F. Hochstrasser, J. C. Sanchez, B. W. Muller, and R. H. Muller, "Colloidal carriers for intravenous drug targeting: plasma protein adsorption on surface-modified polyacrylamide gel electrophoresis," Electrophoresis, 14, 1382-1387 (1993).
33. G. Borchard and J. Kreuter, "Interaction of serum components with poly(methylmethacrylate) nanoparticles and the resulting body distribution after intravenous injection in rats," J. Drug Targeting., 1, 15-19 (1993).
34. J. C. Leroux, P. Gravel, L. Balant, B. Volet, B. M. Anner, E. Allemann, E. Doelker, and R. Gurny, "Internalization of poly(D,L-lactic acid) nanoparticles by isolated human leukocytes and analysis of plasma proteins adsorbed onto the nanoparticles," J. Biomed. Mater. Res. 28, 471-481 (1994).
35. C. R. Jenkin and D. Rowley, "The role of opsonins in the clearance of living and inert particles by cells of the reticuloendothelial system," J. Exp. Med., 114, 363-374 (1961).
36. T. M. Saba and N. R. Di Luzio, "Reticuloencothelial blockade and recovery as a function of opsonic activity," Am. J. Physiol., 213, 197-205 (1969).
37. K. B. Cowper, R. T. Currin, T. L. Dawson, K. A. Lindert, J. J. Lemasters, and R. G. Thurman, "A new method to monitor Kupffer cell function continuously in the perfused rat liver," Biochem. J., 266, 141-147 (1990).
38. R. Fernández-Urrusuno, E. Fattal, D. Porquet, J. Feger, and P. Couvreur, "Evaluation of liver toxicological effects induced by polyalkylcyanoacrylate nanoparticles," Toxicol. Appl. Pharmacol., 130, 272-279 (1995).
39. R. Fernández-Urrusuno, E. Fattal, D. Porquet, J. Feger and P. Couvreur, "Influence of surface properties on the inflammatory response to polymeric nanoparticles," Pharm. Res. 12, 1385-1387 (1995).
40. N. P. Ziats, K. M. Miller, and J. M. Anderson, "In vitro and in vivo interactions of cells with biomaterials," Biomaterials, 9, 5-13 (1988).
41. Z. A. Cohn, "The activation of mononuclear phagocytes: Fact, fancy, and future," J. Immunol., 121, 813-816 (1978).
42. V. Lenaerts, P. Couvreur, D. Christiams-Leyh, E. Joiris, M. Rolland, B. Rollman, and P. Speiser, "Degradation of poly(isobutylcyanoacrylate) nanoparticles," Biomaterials, 5, 65-68 (1984).
43. M. H. Basista, J. Bavaler, A. Stieffenhofer, E. Love, E. Rosenblum, and V. J. Dindzans, "Effect of ethanol on Kupffer cell function," Alcohol. Clin. Exp. Res. 17, 556-560 (1993).
44. S. Gibaud, J. P. Andreux, C. Weingarten, M. Renard, and P. Couvreur, "Increased bone marrow toxicity of Doxorubicin bound to nanoparticles," Eur. J. Cancer, 30, 820-826 (1994).